glp 1 drugs for parkinson's disease How a 'blockbuster' treatment diabetes and obesity might slow or stop – Van Andel Institute GLP-1 receptor agonists show promise
Description
Yes weight loss is a desirable side effect
These medications exert (in)direct hepatic actions by reducing steatosis, attenuating inflammation, and potentially reversing fibrosis, while simultaneously addressing systemic metabolic abnormalities including excessive obesity, insulin resistance, and cardiovascular risk
Some people taking GLP-1 drugs have experienced decreased symptoms of depression
Explore the role of GLP-1 receptor agonists in neuroprotection and their impact on Alzheimer's and Parkinson's diseases.
